141 related articles for article (PubMed ID: 3909342)
1. Clinical experience with aztreonam in Germany and Austria.
Stille W; Gillissen J
Rev Infect Dis; 1985; 7 Suppl 4():S825-30. PubMed ID: 3909342
[TBL] [Abstract][Full Text] [Related]
2. Clinical experience with aztreonam in four Mediterranean countries.
Daikos GK
Rev Infect Dis; 1985; 7 Suppl 4():S831-5. PubMed ID: 2934787
[TBL] [Abstract][Full Text] [Related]
3. Summary of worldwide clinical trials of aztreonam in patients with urinary tract infections.
Swabb EA; Jenkins SA; Muir JG
Rev Infect Dis; 1985; 7 Suppl 4():S772-7. PubMed ID: 3909336
[TBL] [Abstract][Full Text] [Related]
4. Aztreonam in the treatment of serious gram-negative infections in the elderly.
Deger F; Douchamps J; Freschi E; Thys JP; Nève P; Herchuelz A
Int J Clin Pharmacol Ther Toxicol; 1988 Jan; 26(1):22-6. PubMed ID: 3403089
[TBL] [Abstract][Full Text] [Related]
5. Summary of worldwide clinical trials of aztreonam in patients with lower respiratory tract infections.
Swabb EA; Cone CO; Muir JG
Rev Infect Dis; 1985; 7 Suppl 4():S675-8. PubMed ID: 3909323
[TBL] [Abstract][Full Text] [Related]
6. Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Brogden RN; Heel RC
Drugs; 1986 Feb; 31(2):96-130. PubMed ID: 3512234
[TBL] [Abstract][Full Text] [Related]
7. Overall clinical experience with aztreonam in the treatment of intraabdominal infections.
Henry SA
Rev Infect Dis; 1985; 7 Suppl 4():S729-33. PubMed ID: 3909331
[TBL] [Abstract][Full Text] [Related]
8. Clinical studies of aztreonam in Japan.
Hara K; Kobayashi H; Nishiura T; Yura J; Saito A
Rev Infect Dis; 1985; 7 Suppl 4():S810-24. PubMed ID: 3909341
[TBL] [Abstract][Full Text] [Related]
9. The clinical use of aztreonam.
Schönwald S; Schoss-Vidensek Z; Car V; Krznar B
Chemotherapy; 1989; 35 Suppl 1():45-8. PubMed ID: 2731450
[TBL] [Abstract][Full Text] [Related]
10. The use of aztreonam in pediatric patients: a review.
Bosso JA; Black PG
Pharmacotherapy; 1991; 11(1):20-5. PubMed ID: 1902290
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of low-dose aztreonam in the treatment of moderate to severe infections due to gram-negative bacilli.
Clergeot A; Steru D; Rosset MA; Carbon C
Rev Infect Dis; 1991; 13 Suppl 7():S648-51. PubMed ID: 2068476
[TBL] [Abstract][Full Text] [Related]
12. Clinical pharmacology of aztreonam in healthy recipients and patients: a review.
Swabb EA
Rev Infect Dis; 1985; 7 Suppl 4():S605-12. PubMed ID: 3909317
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of aztreonam in the treatment of serious gram-negative bacterial infections.
LeFrock JL; Smith BR; Chandrasekar P; Rolston KV; Molavi A; Kannangara W
Arch Intern Med; 1987 Feb; 147(2):325-8. PubMed ID: 3813751
[TBL] [Abstract][Full Text] [Related]
14. Clinical experience with aztreonam.
Stutman HR
Pediatr Infect Dis J; 1989 Sep; 8(9 Suppl):S109-12; discussion S128-32. PubMed ID: 2682508
[TBL] [Abstract][Full Text] [Related]
15. Overall clinical experience with aztreonam in the treatment of obstetric-gynecologic infections.
Henry SA
Rev Infect Dis; 1985; 7 Suppl 4():S703-8. PubMed ID: 3909327
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics, in-vitro activity, therapeutic efficacy and clinical safety of aztreonam vs. cefotaxime in the treatment of complicated urinary tract infections.
Naber KG; Dette GA; Kees F; Knothe H; Grobecker H
J Antimicrob Chemother; 1986 Apr; 17(4):517-27. PubMed ID: 3710959
[TBL] [Abstract][Full Text] [Related]
17. Aztreonam therapy for serious gram-negative bacillary infections.
Cone LA; Woodard DR
Rev Infect Dis; 1985; 7 Suppl 4():S794-802. PubMed ID: 3909339
[TBL] [Abstract][Full Text] [Related]
18. Aztreonam: worldwide overview of the treatment of patients with gram-negative infections.
Henry SA; Bendush CB
Am J Med; 1985 Feb; 78(2A):57-64. PubMed ID: 3881950
[TBL] [Abstract][Full Text] [Related]
19. Comparison of aztreonam and tobramycin in the treatment of lower respiratory tract infections caused by gram-negative bacilli.
Nolen TM; Phillips HL; Hall HJ
Rev Infect Dis; 1985; 7 Suppl 4():S666-8. PubMed ID: 3909321
[TBL] [Abstract][Full Text] [Related]
20. Clinical experience with aztreonam in Europe: a summary of studies in Belgium, England, Finland, Ireland, the Netherlands, Norway, Portugal, and Sweden.
Norrby SR
Rev Infect Dis; 1985; 7 Suppl 4():S836-9. PubMed ID: 2934788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]